Peter F Aziz1, Tammy Sweeten2, Ramon L Vogel2, William J Bonney2, Jacqueline Henderson2, Akash R Patel3, Maully J Shah2. 1. Department of Pediatrics and Division of Pediatric Cardiology, Cleveland Clinic Children's, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio. 2. The Children's Hospital of Philadelphia, Division of Cardiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania. 3. University of California San Francisco, Pediatric Heart Center, San Francisco, California.
Abstract
OBJECTIVE: The study sought to examine the prevalence and outcomes of sports participation (both competitive and recreational) in our single-center LQTS genotype positive pediatric population. BACKGROUND: The risks of sports participation in patients with long QT syndrome (LQTS) are not clearly elucidated. METHODS: A retrospective review was performed on genotype positive patients referred for the evaluation and management of LQTS between 1998 and 2013 at the Children's Hospital of Philadelphia. Pediatric patients participating in competitive or recreational sports were included in the analysis and their charts were reviewed for documented LQTS events during follow-up. RESULTS: The cohort of genotype-positive LQTS patients included 212 patients, and 103 patients (49%, female n = 53, average follow-up 7.1 ± 4.0 years, average QTc 468 ± 42 ms) participated in sports. A total of 105 LQTS disease-causing mutations were identified: KCNQ1 n = 60 (58%), KCNH2 n = 36 (35%), SCN5A n = 6 (6%), KCNE1 n = 1 (1%), and KCNE2 n = 2 (2%). All patients were treated with beta-blockade, with noncompliance in 1 patient and intolerance in 1 patient. Twenty-six patients participated in competitive sports (26%, female n = 15, average follow-up 6.9 ± 4.1 years, average QTc 461 ± 35 ms). Seventy-seven patients (75%, female n = 35, average follow-up 7.3 ± 3.9 years, average QTc 470 ± 43 ms) participated in recreational sports. No patients had LQTS symptoms during sports participation. Five appropriate implantable cardioverter-defibrillator shocks occurred in 2 patients, though none were related to sports participation. CONCLUSIONS: In this series no cardiac events and no deaths were observed in treatment-compliant LQTS children while participating in sports in 755 patient-years of follow-up.
OBJECTIVE: The study sought to examine the prevalence and outcomes of sports participation (both competitive and recreational) in our single-center LQTS genotype positive pediatric population. BACKGROUND: The risks of sports participation in patients with long QT syndrome (LQTS) are not clearly elucidated. METHODS: A retrospective review was performed on genotype positive patients referred for the evaluation and management of LQTS between 1998 and 2013 at the Children's Hospital of Philadelphia. Pediatric patients participating in competitive or recreational sports were included in the analysis and their charts were reviewed for documented LQTS events during follow-up. RESULTS: The cohort of genotype-positive LQTS patients included 212 patients, and 103 patients (49%, female n = 53, average follow-up 7.1 ± 4.0 years, average QTc 468 ± 42 ms) participated in sports. A total of 105 LQTS disease-causing mutations were identified: KCNQ1 n = 60 (58%), KCNH2 n = 36 (35%), SCN5A n = 6 (6%), KCNE1 n = 1 (1%), and KCNE2 n = 2 (2%). All patients were treated with beta-blockade, with noncompliance in 1 patient and intolerance in 1 patient. Twenty-six patients participated in competitive sports (26%, female n = 15, average follow-up 6.9 ± 4.1 years, average QTc 461 ± 35 ms). Seventy-seven patients (75%, female n = 35, average follow-up 7.3 ± 3.9 years, average QTc 470 ± 43 ms) participated in recreational sports. No patients had LQTS symptoms during sports participation. Five appropriate implantable cardioverter-defibrillator shocks occurred in 2 patients, though none were related to sports participation. CONCLUSIONS: In this series no cardiac events and no deaths were observed in treatment-compliant LQTS children while participating in sports in 755 patient-years of follow-up.
Entities:
Keywords:
cardiac arrest; long QT syndrome; pediatrics; sports participation
Authors: Douglas P Zipes; Michael J Ackerman; N A Mark Estes; Augustus O Grant; Robert J Myerburg; George Van Hare Journal: J Am Coll Cardiol Date: 2005-04-19 Impact factor: 24.094
Authors: A J Moss; J L Robinson; L Gessman; R Gillespie; W Zareba; P J Schwartz; G M Vincent; J Benhorin; E L Heilbron; J A Towbin; S G Priori; C Napolitano; L Zhang; A Medina; M L Andrews; K Timothy Journal: Am J Cardiol Date: 1999-10-15 Impact factor: 2.778
Authors: Barry J Maron; Bernard R Chaitman; Michael J Ackerman; Antonio Bayés de Luna; Domenico Corrado; Jane E Crosson; Barbara J Deal; David J Driscoll; N A Mark Estes; Claudio Gil S Araújo; David H Liang; Matthew J Mitten; Robert J Myerburg; Antonio Pelliccia; Paul D Thompson; Jeffrey A Towbin; Steven P Van Camp Journal: Circulation Date: 2004-06-08 Impact factor: 29.690
Authors: Rachel Lampert; Brian Olshansky; Hein Heidbuchel; Christine Lawless; Elizabeth Saarel; Michael Ackerman; Hugh Calkins; N A Mark Estes; Mark S Link; Barry J Maron; Frank Marcus; Melvin Scheinman; Bruce L Wilkoff; Douglas P Zipes; Charles I Berul; Alan Cheng; Ian Law; Michele Loomis; Cheryl Barth; Cynthia Brandt; James Dziura; Fangyong Li; David Cannom Journal: Circulation Date: 2013-05-21 Impact factor: 29.690
Authors: Nabil Ghorayeb; Ricardo Stein; Daniel Jogaib Daher; Anderson Donelli da Silveira; Luiz Eduardo Fonteles Ritt; Daniel Fernando Pellegrino Dos Santos; Ana Paula Rennó Sierra; Artur Haddad Herdy; Claúdio Gil Soares de Araújo; Cléa Simone Sabino de Souza Colombo; Daniel Arkader Kopiler; Filipe Ferrari Ribeiro de Lacerda; José Kawazoe Lazzoli; Luciana Diniz Nagem Janot de Matos; Marcelo Bichels Leitão; Ricardo Contesini Francisco; Rodrigo Otávio Bougleux Alô; Sérgio Timerman; Tales de Carvalho; Thiago Ghorayeb Garcia Journal: Arq Bras Cardiol Date: 2019-03 Impact factor: 2.000
Authors: Rui Providencia; Carina Teixeira; Oliver R Segal; Augustus Ullstein; Kim Mueser; Pier D Lambiase Journal: Europace Date: 2018-08-01 Impact factor: 5.214
Authors: Kristina D Chambers; Virginie Beausejour Ladouceur; Mark E Alexander; Robyn J Hylind; Laura Bevilacqua; Douglas Y Mah; Vassilios Bezzerides; John K Triedman; Edward P Walsh; Dominic J Abrams Journal: J Am Heart Assoc Date: 2017-09-21 Impact factor: 5.501